Difference between revisions of "Part:BBa K4165093"
Omnia Alaa11 (Talk | contribs) |
Omnia Alaa11 (Talk | contribs) |
||
(4 intermediate revisions by 3 users not shown) | |||
Line 15: | Line 15: | ||
===Functional Parameters=== | ===Functional Parameters=== | ||
− | |||
− | |||
− | |||
− | |||
− | Charge at pH 7 | + | <html> |
− | -2.188 | + | <style> |
+ | table, th, td { | ||
+ | border:1px solid black; margin-left:auto;margin-right:auto; | ||
+ | } | ||
+ | </style> | ||
+ | <body> | ||
+ | <table style="width:65%"> | ||
+ | <table> | ||
+ | <tr> | ||
+ | <th>GC Content%</th> | ||
+ | <th>Isoelectric point (PI)</th> | ||
+ | <th>Charge at pH 7</th> | ||
+ | <th>Molecular Weight (Protein)</th> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>60.9%</td> | ||
+ | <td>4.993</td> | ||
+ | <td>-2.188</td> | ||
+ | <td>15.535 kDa</td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | </body> | ||
+ | </html> | ||
− | |||
− | |||
− | === | + | ===Modeling=== |
− | + | ||
The predicted structure (AlphaFold) is present. | The predicted structure (AlphaFold) is present. | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
Line 48: | Line 53: | ||
</html> | </html> | ||
− | + | Figure 1.: A graphical illustration showing the structure of the inhibitor. | |
===References=== | ===References=== |
Latest revision as of 11:44, 13 October 2022
Histocompatibility minor serpin domain (HMSD).
This basic part encodes Histocompatibility minor serpin domain which is predicted to be able to inhibit HtrA1 (BBa_K4165004).
Usage and Biology
This gene encodes a protein with a serpin domain that may act as a serine protease inhibitor. This gene is predominantly expressed in myeloid cells. A splice variant encoding a minor histocompatibility antigen may be expressed as a result of a polymorphism in this gene. This type of inhibitor is predicted to have a high affinity for trypsin-like proteases (serine proteases), and in our case, it would act as an inhibitor for the trypsin-like catalytic domain of serine protease HtrA1[1-3].
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 400
- 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 400
- 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 400
- 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 400
- 1000COMPATIBLE WITH RFC[1000]
Functional Parameters
GC Content% | Isoelectric point (PI) | Charge at pH 7 | Molecular Weight (Protein) |
---|---|---|---|
60.9% | 4.993 | -2.188 | 15.535 kDa |
Modeling
The predicted structure (AlphaFold) is present.
Figure 1.: A graphical illustration showing the structure of the inhibitor.
References
1. Clauss, A., Lilja, H., & Lundwall, Å. (2005). The evolution of a genetic locus encoding small serine proteinase inhibitors. Biochemical and biophysical research communications, 333(2), 383-389.
2. Eigenbrot, C., Ultsch, M., Lipari, M. T., Moran, P., Lin, S. J., Ganesan, R., ... & Kirchhofer, D. (2012). Structural and functional analysis of HtrA1 and its subdomains. Structure, 20(6), 1040-1050.
3. Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., ... & Ehrmann, M. (2005). Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proceedings of the National Academy of Sciences, 102(17), 6021-6026.